Results 71 to 80 of about 9,231 (199)
Treatment and management of myelofibrosis in the era of JAK inhibitors [Corrigendum]
, 2013 Keohane C, Radia DH, Harrison CN. Biologics: Targets and Therapy. 2013;7:189–198. On page 193 note that the paragraph beginning "Pacritinib (SB1518; Cell Technology, Inc, Mountain View, CA, USA) is a JAK2 and FLT3 inhibitor currently being ...
Keohane C, Radia DH, Harrison CN
core
Thalidomide treatment of a dog with myelofibrosis
Myelofibrosis is characterised by the proliferation of fibroblasts. The exact aetiopathogenesis of myelofibrosis in dogs remains unknown. The use of thalidomide is established as a treatment option for humans with myelofibrosis.
Darren Kelly +2 more
core +1 more source
, 2013 §P value refers to the difference between prefibrotic myelofibrosis and myelofibrosis-fibrotic type;§§P value refers to the difference between prefibrotic myelofibrosis and myelofibrosis-fibrotic type with bone marrow (BM) fibrosis grade 1;§§§P value ...
Paolo Catarsi (325689) +12 more
core +1 more source
European Journal of Haematology, EarlyView.ABSTRACT Introduction Central venous catheter (CVC) insertion is frequently required in patients with haematological diseases. Despite limited evidence, thrombocytopenia often prompts prophylactic platelet transfusion before catheterisation. Methods We conducted an observational before‐and‐after study including the first non‐tunnelled CVC insertion ...
Mathias Lazarevic Lindblad +8 more
wiley +1 more source
Idiopathic splanchnic vein thrombosis: is it really idiopathic?
Haematologica, 2022 Giovanni Barosi
doaj +1 more source
Recent developments in myelofibrosis
, 2012 Raoul Tibes, James M Bogenberger, Ruben A MesaDivision of Hematology and Oncology, Mayo Clinic, Scottsdale, AZ, USAAbstract: The myeloproliferative neoplasm of myelofibrosis (MF) is clinically constituted by individuals both with primary MF, as well as ...
Tibes R, Mesa RA, Bogenberger JM
core
Myelofibrosis and True Histiocytic Lymphoma
, 1985 A 60-year-old female presented with a history of progressive shortness of breath, fever, and weight loss of 55 pounds. The work-up consisting of computerized axial tomography (CT) scan of thorax and abdomen, mediastinoscopy, and bilateral bone marrow ...
Ila Shah-Reddy +2 more
core +1 more source
Efficacy of ruxolitinib retreatment in a patient with high-risk myelofibrosis using the international prognostic scoring system [PDF]
, 2019 Primary myelofibrosis (PMF) is a myeloproliferative neoplasm in which clonal proliferation of hematopoietic stem cells and bone marrow fibrosis coexist.1 Patients may eventually die due to leukemic progression, which occurs in up to 20% of cases, or ...
Di Piazza, Florinda +13 more
core +1 more source
European Journal of Haematology, EarlyView.ABSTRACT This retrospective, single‐center study aimed to characterize clonal dynamics of GPI‐deficient cells in patients with paroxysmal nocturnal hemoglobinuria (PNH) or PNH/aplastic anemia (AA) syndrome using multiparameter flow cytometry including FLAER.
Sandra M. Frey +6 more
wiley +1 more source
Real-world patient characteristics and clinical outcomes in patients with myelofibrosis in Japan.
PLoS ONEAnemia is associated with increased morbidity, mortality, healthcare resource utilization, and costs in myelofibrosis. This longitudinal, retrospective, and descriptive cohort study used a Japanese health administrative database (Medical Data Vision) to ...
Yusuke Yasutomi +7 more
doaj +1 more source